Page last updated: 2024-08-23

paclitaxel and Cancer of Nasopharynx

paclitaxel has been researched along with Cancer of Nasopharynx in 108 studies

Research

Studies (108)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	8 (7.41)	18.2507
2000's	27 (25.00)	29.6817
2010's	59 (54.63)	24.3611
2020's	14 (12.96)	2.80

Authors

Authors	Studies
Chen, Y; Ding, X; Feng, G; Huang, Y; Lin, L; Ma, S; Wang, R; Xu, R; Yang, Y; Zhang, C; Zhang, L; Zhou, T	1
Cao, KJ; Chen, MY; Chen, QY; Chen, ZJ; Guo, L; Guo, X; Hu, D; Hua, YJ; Huang, PY; Ke, LR; Li, WZ; Liang, H; Liu, GY; Liu, T; Lu, N; Luo, DH; Lv, SH; Lv, X; Mai, HQ; Mo, HY; Qian, CN; Qiu, F; Sun, R; Tang, LQ; Tang, WB; Tong, LH; Wang, DS; Wang, L; Xia, WX; Xiang, YQ; Yang, W; Ye, YF; Yuan, TZ; Zhang, HX; Zhao, C	1
Li, X; Lu, W; Yang, L; Zhao, F; Zhou, T	1
Fang, W; He, H; Hong, S; Huang, Y; Lin, Y; Lin, Z; Ma, Y; Salamone, SJ; Wu, Y; Xue, J; Yang, Y; Zhang, L; Zhang, Y; Zhao, H	1
Cao, K; Chen, H; Cheng, Y; Wang, Z; Xiao, M; Zhang, Y; Zhu, Y	1
Li, X; Ling, F; Long, W; Sun, X; Xu, S	1
Chen, Y; Cui, X; Ding, X; Zhao, L	1
Jiang, B; Li, Y; Ni, H; Zhou, Z	1
Chuan, Z; Hui, Z; Jiafeng, Z; Miaomiao, Z; Ping, H; Qiongna, D; Xiaojie, J; Yalin, H; Yiting, S	1
Zhu, H	1
Li, H; Song, Y; Wang, K; Wang, X; Xiao, J	1
Yuan, F; Zhou, ZF	1
Chen, HY; Feng, HJ; Su, JP; Zhao, C; Zhao, F	1
Hu, J; Hu, L; Jiang, B; Jiang, M; Liu, X; Pan, X; Zeng, H	1
Hao, S; Wang, Q; Zhang, W	1
Fong, KW; Hussain, A; Ong, WS; Sommat, K; Soong, YL; Tan, T; Wee, J	1
Fu, T; Gao, J; Shao, Z; Yan, M; Yan, Y; Zhang, L	1
Hu, WH; Jin, T; Li, PJ; Luo, DH; Mo, HY	1
Fan, J; Fan, Y; He, X; Li, L; Mu, J; Ren, G; Sun, X; Tao, Q; Xiang, Q; Xiang, T; Yang, Y; Zhang, Y; Zhou, D	1
Li, B; Liao, W; Wen, H; Xu, P; Zhang, S; Zheng, L	1
Liu, L; Liu, P; Lou, P; Lv, T; Ou, D; Qin, S; Wang, X; Wang, Y	1
Chao, H; Chen, H; Hu, C; Huang, L; Li, H; Lu, H; Wang, R	1
Bo, H; Cao, K; Gong, L; He, D; Li, R; Li, W; Liu, X; Liu, Y; Liu, Z; Ma, Y; Xiang, L; Xiao, M; Xing, X; Xiong, W; Yang, F; Zhou, J; Zhou, M; Zhou, Y; Zhu, Y	1
Cao, CN; Gao, L; Luo, JW; Tang, PZ; Xu, GZ; Xu, ZG	1
Bian, X; Cheng, K; Guo, W; He, X; Huang, S; Jiang, X; Xu, J; Zhang, L	1
Chan, AT; Cheng, SH; Cheung, CS; Ho, K; Hui, CW; Hui, EP; Lau, CP; Lui, VW; Ma, BB; Ng, MH; Tsang, CM; Tsao, SW; Wong, CH	1
Gu, MF; Huang, SM; Su, Y; Wu, Z; Zeng, RF	1
Chen, MY; Guo, L; Hong, MH; Huang, HQ; Jiang, R; Liu, Q; Mai, HQ; Qian, CN; Qiu, F; Sun, R; Xia, ZJ; Zhang, L; Zou, X	1
Bode, AM; Cao, Y; Dong, Z; Gao, J; Tang, M; Weng, X; Wu, Y; Xu, W; Yang, L; Yi, W	1
Deng, W; Guan, Z; Huang, M; Huang, W; Jiang, W; Kang, T; Li, L; Li, S; Liu, Q; Liu, R; Pan, C; Tan, W; Thomas, GR; Wu, J; Ye, W; Ying, X; Zeng, M; Zhang, L	1
Chen, X; Mou, J; Pan, X; Peng, G; Zou, Z	1
Li, G; Liu, Y; Qiu, Y; Ren, S; Su, Z; Tan, P; Tian, Y; Wang, Y; Zhang, X	1
Cao, K; Cao, P; Han, S; He, D; Li, W; Li, Z; Peng, X; Tan, G; Yu, F; Yu, J; Zhou, J	1
Cao, Y; Gao, J; Huang, J; Liu, M; Sun, L; Tang, M; Wang, X; Weng, X; Yang, L; Yi, W; Zeng, W; Zhou, M	1
Cao, K; Cao, P; Han, S; He, D; Li, J; Li, W; Li, Z; Peng, X; Tan, G; Yu, F; Yu, J; Zhou, J	1
Ang, MK; Cheah, SL; Fong, KW; Lim, WT; Ng, QS; Ong, WS; Quah, D; Soo, KC; Soong, YL; Tan, D; Tan, SH; Tan, T; Wee, J; Yip, C	1
Ding, N; Feng, D; Liu, Q; Sun, LQ; Tan, G; Wang, X; Xie, B; Yang, X; Zhang, J; Zhang, L; Zhou, Z	1
Hou, C; Tan, T; Yang, N; Zhu, L	1
Hidaka, T; Ishiguro, Y; Kameda, T; Kamiunten, A; Kawabata, T; Kitanaka, A; Kubuki, Y; Miyaushiro, S; Sekine, M; Shide, K; Shimoda, K; Umekita, Y	1
Huang, CB; Huang, LL; Lin, SJ; Pan, JJ; Qiu, SF; Xu, YJ; Zheng, W; Zong, JF	1
Lan, XW; Mao, YP; OuYang, PY; Su, Z; Tang, J; Xie, FY	1
Peng, X; Song, Y; Tan, G; Wang, M; Xie, J	1
Li, W; Peng, X; Qin, J; Song, Y; Tan, G; Xiang, H; You, Y; Zhang, X	1
Li, T	1
Li, G; Liu, C; Liu, Y; Qiu, Y; Ren, S; Su, Z; Tian, Y	1
Chen, S; Chen, X; Liao, Y; Lin, X; Long, D; Shen, F; Yu, T; Zhang, L	1
Jiang, YX; Li, YH; Liang, Y; Luo, HY; Wang, DS; Wang, FH; Wang, Y; Wang, ZQ	1
Huang, Y; Liang, W; Wu, X; Yang, Y; Zhang, L; Zhang, Y; Zhao, H; Zhao, L; Zhao, Y	1
Cai, T; Li, G; Liu, C; Liu, Y; Qiu, Y; Ren, S; She, L; Su, Z; Tian, Y; Wang, Y; Wei, M; Zhang, X	1
Hou, J; Hu, Y; Li, F; Lu, Q; Wang, H; Wang, L; Xiang, W; Yu, X; Zeng, W; Zhang, Z	1
Duan, Y; Fan, X; Gong, Z; Gulina, K; Hou, Y; Jiang, Z; Li, J; Li, X; Li, Z; Liu, Y; Peng, Y; Sun, L; Tan, G; Xie, B; Yin, L; Yu, X; Yuan, B; Zhu, Q	1
Hee, SW; Leong, SS; Lim, WT; Poon, D; Rajan, S; Tan, EH; Tay, MH; Toh, CK; Wee, J	1
Ding, W; Hu, W; Jin, L; Ma, CC; Shao, M; Wang, B; Wang, J; Wu, S; Yang, H	1
Arpicco, S; Brusa, P; Cattel, L; Dosio, F; Stella, B	1
He, XY; Hu, CS; Liu, TF; Wu, YR; Ying, HM; Zhu, GP	1
Bai, YX; Li, HH; Pan, CE; Quan, F; Yao, XB; Yu, L; Zhang, SQ	1
Bao, JM; Li, D; Li, SJ; Li, Z; Ma, YP; Meng, DW	1
Liu, Y; Qiu, Y; Tian, Y; Wang, C; Xiao, J; Zhang, S; Zhao, S	1
Li, W; Peng, X; Tan, G	1
Chen, H; Lin, JR; Xie, B; Xu, ZY; Zhang, WM; Zheng, JH; Zhou, J	1
Chen, Q; Han, L; Lin, S; Lu, JJ; Pan, J	1
Hakoshima, M; Hattori, Y; Koga, K; Maitani, Y	1
Airoldi, M; Beatrice, F; Gabriele, AM; Gabriele, P; Garzaro, M; Giordano, C; Pecorari, G; Pedani, F; Raimondo, L	1
Luo, RC; Zuo, Q	1
He, GX; Li, W; Ma, YH; Peng, XW; Tan, GL	1
Athanassiou, H; Bobos, M; Ciuleanu, E; Ciuleanu, T; Dionysopoulos, D; Eleftheraki, AG; Fountzilas, G; Kalogera-Fountzila, A; Karayannopoulou, G; Markou, K; Misailidou, D; Nikolaou, A; Resiga, L; Samantas, E; Skarlos, D; Zaramboukas, T	1
Cullen, KJ; Goloubeva, O; Kwok, Y; Ord, R; Parekh, A; Strome, S; Suntharalingam, M; Taylor, R; Wolf, J; Zimrin, A	1
Dai, YY; Jiang, WZ; Wan, LY; Wei, R; Yang, DY; Yang, Z	1
He, G; Li, H; Li, W; Ma, Y; Tan, G	1
Cai, XY; Cai, YC; Cao, Y; Jiang, WQ; Jin, Y; Shi, YX; Tan, YT	1
Peng, X; Tan, G	1
Cai, XY; Cai, YC; Cao, Y; Hu, WH; Jiang, WQ; Jin, Y; Shi, YX; Xia, XY; Zhang, WD	1
Guo, Y; Huang, D; Li, G; Li, S; Liu, Y; Qiu, Y; Tan, P; Tian, Y; Xiao, J; Zhang, X	1
Huang, WL; Li, XY; Lin, SL; Lin, W; Lin, WZ; Lin, YC; Wang, HB	1
He, G; Li, H; Li, W; Ma, Y; Tan, G; Zhang, X	1
Drage, MG; Haddad, RI; Lichtman, AH; Shah, SM	1
An, X; Chen, C; Li, YH; Liang, Y; Luo, HY; Wang, FH; Wang, ZQ; Zhang, L	1
Chan, AT; Hui, CW; Hui, EP; Lau, CP; Li, Y; Lui, VW; Ma, BB; Ng, MH; Tsao, SW; Wong, CH	1
Jiang, C; Jiang, Z; Liu, H; Pu, L; Song, L; Zhang, P; Zhao, S	1
He, CX; Jin, Y; Lin, BC; Shao, L; Ye, X; Zhang, BB; Zhang, YP	1
Degendorfer, P; Furlan, M; McCarthy, JS; Panzarella, T; Siu, LL; Tannock, IF	1
Airoldi, M; Bumma, C; Cortesina, G; Giordano, C; Pedani, F	1
Cheung, HW; Guan, XY; Lee, DT; Ling, MT; Tsao, SW; Wang, X; Wong, YC	1
Cheung, HW; Ling, MT; Tsao, SW; Wang, X; Wong, YC	1
Chan, AT; Chan, LS; Cheung, KY; Chiu, SK; Hui, EP; Johnson, PJ; Kam, M; King, A; Kwan, WH; Lai, K; Lai, M; Leung, SF; Lo, YM; Ma, BB; Mo, F; Mok, TS; Teo, PM; Yeo, W; Yu, KH; Zee, B	1
Guan, ZZ; Hawkins, M; Liu, DG; Luo, HY; Soon-Shiong, P; Teng, XY; Yao, ZW; Zhou, NN	1
Bao, Y; Chen, M; Chen, YY; Cui, NJ; Deng, XW; Li, Q; Lin, HX; Lu, LX; Lu, TX; Wu, SX; Xian, CG	1
Foo, KF; Leong, SS; Lim, WT; Tan, EH; Tan, SB; Tan, T; Tay, MH; Thng, CH; Toh, CK; Wee, J	1
Athanassiou, E; Bai, M; Catodritis, N; Daniilidis, J; Fountzilas, G; Kalogera-Fountzila, A; Karanikiotis, C; Makatsoris, T; Misailidou, D; Nicolaou, A; Papakostas, P; Papamichael, D; Plataniotis, G; Samantas, E; Tolis, C; Tsekeris, P; Zamboglou, N	1
Chen, CL; Cheng, AL; Gao, M; Hsu, CH; Yeh, PY	1
Chua, ET; Goh, BC; Hsieh, WS; Lim, HL; Loh, KS; Lu, JJ; Shakespeare, TP; Soo, RA; Tan, KS; Wong, AS	1
Ling, MT; Wang, X; Wong, YC; Zhang, X	1
Leung, SC; Ling, MT; Wang, Q; Wang, X; Wong, YC; Zhang, X	1
Chen, CY; Han, F; Lu, LX; Lu, TX; Sun, Y; Zhao, C	1
Gao, L; Jin, J; Liu, XF; Xu, GZ; Yang, WZ; Yuan, ZY	1
Barakat, HM; Ibrahim, SA; Mostafa, E; Nasar, MN; Rabie, AN; Rabie, NA	1
Chao, Y; Chen, LT; Chen, YM; Chou, CM; Liu, JM; Liu, TW; Whang-Peng, J; Yu, WL	1
Athanassiades, A; Bacoyiannis, C; Briasoulis, E; Daniilidis, J; Dinopoulou, M; Dombros, N; Fountzilas, G; Kalogera-Fountzila, A; Kosmidis, P; Nicolaou, A; Pavlidis, N; Samantas, E; Skarlos, D; Stathopoulos, G	1
Capri, G; Cavina, R; Fulfaro, F; Gianni, L; Grandi, C; Licitra, L; Tarenzi, E	1
Ang, PT; Au, E; Tan, EH	1
Akbulut, S; Atahan, IL; Kiratli, H; Ozyar, E; Uzal, D	1
Chan, AT; Chiu, SK; Johnson, PJ; Leung, TW; Mok, TS; Yeo, W; Yu, P	1
Au, E; Chua, EJ; Chua, ET; Fong, KW; Khoo, KS; Khoo-Tan, HS; Lee, KM; Lee, KS; Ong, YK; Tan, EH; Tan, T; Tao, M; Wee, J; Yang, TL	1
Guan, Z; Lin, T; Wu, H	1
Chen, HC; Chen, WP; Lin, CT; Lou, PJ; Wu, JC	1
Chao, Y; Chen, LL; Chen, SN; Huang, TS; Shu, CH	1
Chao, Y; Chen, LT; Huang, TS; Shu, CH	1
Heqing, L; Hong, S; Jiangbo, C; Li, G; Ming, J; Tan, G; Xianghe, L; Yanhong, M	1

Reviews

1 review(s) available for paclitaxel and Cancer of Nasopharynx

Article	Year
Ifosfamide in the treatment of head and neck cancer. Oncology, 2003, Volume: 65 Suppl 2 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Head and Neck Neoplasms; Humans; Ifosfamide; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Paclitaxel; Treatment Outcome	2003

Trials

28 trial(s) available for paclitaxel and Cancer of Nasopharynx

Article	Year
Bevacizumab versus placebo in combination with paclitaxel and carboplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase II trial. ESMO open, 2021, Volume: 6, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Humans; Lung Neoplasms; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Paclitaxel	2021
Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial. JAMA oncology, 2022, 05-01, Volume: 8, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Cisplatin; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Paclitaxel	2022
Paclitaxel exposure-toxicity analysis reveals a pharmacokinetic determinant for dose-limiting neutropenia in East-Asian solid tumor patients: results from two prospective, phase II studies. Cancer chemotherapy and pharmacology, 2022, Volume: 90, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Nasopharyngeal Neoplasms; Neutropenia; Paclitaxel; Prospective Studies	2022
Thyroid V40 Predicts Primary Hypothyroidism After Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma. International journal of radiation oncology, biology, physics, 2017, 07-01, Volume: 98, Issue:3 Topics: Adult; Age Factors; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Chemoradiotherapy; Cisplatin; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Hypothyroidism; Incidence; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; Pituitary Gland; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Regression Analysis; Thyroid Gland; Time Factors	2017
IMRT combined with S-1 concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a prospective phase II study. Investigational new drugs, 2019, Volume: 37, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Organoplatinum Compounds; Oxonic Acid; Paclitaxel; Prognosis; Prospective Studies; Radiotherapy, Intensity-Modulated; Survival Rate; Tegafur; Young Adult	2019
Multicenter randomized phase 2 clinical trial of a recombinant human endostatin adenovirus in patients with advanced head and neck carcinoma. Molecular therapy : the journal of the American Society of Gene Therapy, 2014, Volume: 22, Issue:6 Topics: Adenoviridae; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Endostatins; Genetic Therapy; Genetic Vectors; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Paclitaxel; Recombinant Proteins; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Treatment Outcome; Young Adult	2014
Concurrent chemo-radiation with or without induction gemcitabine, Carboplatin, and Paclitaxel: a randomized, phase 2/3 trial in locally advanced nasopharyngeal carcinoma. International journal of radiation oncology, biology, physics, 2015, Apr-01, Volume: 91, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Chemoradiotherapy; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; Patient Compliance; Quality of Life; Radiation-Sensitizing Agents	2015
Phase I/II dose-finding study of nanoparticle albumin-bound paclitaxel (nab®-Paclitaxel) plus Cisplatin as Treatment for Metastatic Nasopharyngeal Carcinoma. BMC cancer, 2016, 07-13, Volume: 16 Topics: Adult; Albumin-Bound Paclitaxel; Albumins; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Immunohistochemistry; Male; Maximum Tolerated Dose; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Osteonectin; Paclitaxel; Treatment Outcome	2016
Weekly paclitaxel with concurrent radiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2009, Volume: 93, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Paclitaxel; Radiotherapy Dosage; Radiotherapy, High-Energy	2009
Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeC Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma; Chemoradiotherapy; Cisplatin; Epirubicin; Female; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Ki-67 Antigen; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; Prognosis; Proportional Hazards Models; Tumor Suppressor Protein p53; Young Adult	2012
Phase II study evaluating the addition of cetuximab to the concurrent delivery of weekly carboplatin, paclitaxel, and daily radiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck. International journal of radiation oncology, biology, physics, 2012, Apr-01, Volume: 82, Issue:5 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Drug Administration Schedule; ErbB Receptors; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Papillomaviridae; Prospective Studies; Remission Induction; Squamous Cell Carcinoma of Head and Neck	2012
[Efficacy of Yanshu injection (a compound Chinese traditional medicine) combined with concurrent radiochemotherapy in patients with stage III nasopharyngeal carcinoma]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2011, Volume: 33, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Drugs, Chinese Herbal; Female; Follow-Up Studies; Humans; Leukopenia; Male; Medicine, Chinese Traditional; Mucositis; Nasopharyngeal Neoplasms; Neoplasm Staging; Paclitaxel; Plants, Medicinal; Quality of Life; Radiotherapy, Intensity-Modulated; Sophora; Survival Rate; Thrombocytopenia	2011
Triplet combination with paclitaxel, cisplatin and 5-FU is effective in metastatic and/or recurrent nasopharyngeal carcinoma. Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Female; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Paclitaxel; Prognosis	2013
A Phase II trial of docetaxel and cisplatin in patients with recurrent or metastatic nasopharyngeal carcinoma. Oral oncology, 2002, Volume: 38, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Taxoids; Treatment Outcome	2002
Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Aug-01, Volume: 22, Issue:15 Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; DNA, Viral; Drug Administration Schedule; Environmental Monitoring; Female; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Paclitaxel; Survival Rate	2004
[A tolerability study of A cremophor-free albumin bound nanoparticle paclitaxel intravenously administered in patients with advanced solid tumor]. Ai zheng = Aizheng = Chinese journal of cancer, 2004, Volume: 23, Issue:11 Suppl Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Diplopia; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Nanotechnology; Nasopharyngeal Neoplasms; Neutropenia; Paclitaxel	2004
Radiation therapy concurrent with weekly paclitaxel for locoregionally advanced nasopharyngeal carcinoma: outcomes of a phase I trial. American journal of clinical oncology, 2004, Volume: 27, Issue:5 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Combined Modality Therapy; Dose Fractionation, Radiation; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Nasopharyngeal Neoplasms; Paclitaxel; Radiotherapy, High-Energy	2004
Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma: a Phase II trial using a triplet combination. Cancer, 2005, Feb-01, Volume: 103, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neutropenia; Paclitaxel; Severity of Illness Index; Survival Analysis; Thrombocytopenia; Treatment Outcome	2005
Induction chemotherapy with cisplatin, epirubicin, and paclitaxel (CEP), followed by concomitant radiotherapy and weekly paclitaxel for the management of locally advanced nasopharyngeal carcinoma. A Hellenic Cooperative Oncology Group phase II study. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2005, Volume: 181, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Epirubicin; Female; Humans; Leukocyte Count; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Paclitaxel; Patient Selection; Platelet Count	2005
Paclitaxel, 5-fluorouracil and hydroxyurea concurrent with radiation in locally advanced nasopharyngeal carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorouracil; Humans; Hydroxyurea; Male; Middle Aged; Nasopharyngeal Neoplasms; Paclitaxel; Survival Analysis; Treatment Failure	2006
[Weekly paclitaxel with concurrent intensity-modulated radiotherapy for nasopharyngeal carcinoma: outcomes of a tolerance trial]. Ai zheng = Aizheng = Chinese journal of cancer, 2007, Volume: 26, Issue:4 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease-Free Survival; Drug Tolerance; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mucositis; Nasopharyngeal Neoplasms; Neoplasm Staging; Paclitaxel; Radiotherapy, Intensity-Modulated; Remission Induction	2007
Induction chemotherapy with paclitaxel and cisplatin, followed by concomitant cisplatin and radiotherapy for the treatment of locally advanced nasopharyngeal carcinoma. Journal of the Egyptian National Cancer Institute, 2006, Volume: 18, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease Progression; Female; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Paclitaxel; Patient Compliance; Radiotherapy; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome	2006
Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck. A phase II study conducted by the Hellenic Cooperative Oncology Group. Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Paclitaxel	1997
Biweekly paclitaxel and cisplatin in patients with advanced head and neck carcinoma. A phase II trial. Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Nasopharyngeal Neoplasms; Paclitaxel; Palliative Care; Treatment Outcome	1997
Activity of paclitaxel by three-hour infusion in Asian patients with metastatic undifferentiated nasopharyngeal cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Nasopharyngeal Neoplasms; Paclitaxel; Survival Rate; Treatment Outcome	1998
A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma. European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:13 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Hematologic Diseases; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Paclitaxel; Prospective Studies; Survival Analysis; Treatment Outcome	1998
Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Paclitaxel; Survival Rate	1999
[A phase II clinical study of China-made paclitaxel in the treatment of cancer patients]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 1998, Volume: 20, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Neutropenia; Ovarian Neoplasms; Paclitaxel	1998

Other Studies

79 other study(ies) available for paclitaxel and Cancer of Nasopharynx

Article	Year
Timosaponin AIII Suppresses RAP1 Signaling Pathway to Enhance the Inhibitory Effect of Paclitaxel on Nasopharyngeal Carcinoma. Computational and mathematical methods in medicine, 2022, Volume: 2022 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Guanine Nucleotide Exchange Factors; Humans; Mice; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; Saponins; Signal Transduction; Steroids; Xenograft Model Antitumor Assays	2022
circRNA_0067717 promotes paclitaxel resistance in nasopharyngeal carcinoma by acting as a scaffold for TRIM41 and p53. Cellular oncology (Dordrecht), 2023, Volume: 46, Issue:3 Topics: Cell Line, Tumor; Cell Proliferation; Humans; In Situ Hybridization, Fluorescence; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; RNA, Circular; Tumor Suppressor Protein p53; Ubiquitin-Protein Ligases	2023
Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy. BMC cancer, 2023, Feb-20, Volume: 23, Issue:1 Topics: Chemoradiotherapy; Humans; Induction Chemotherapy; Ki-67 Antigen; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; Poly(A)-Binding Protein I; Poly(A)-Binding Proteins; Prognosis; Tumor Suppressor Protein p53	2023
Extracellular vesicles derived from paclitaxel-sensitive nasopharyngeal carcinoma cells deliver miR-183-5p and impart paclitaxel sensitivity through a mechanism involving P-gp. Cell biology and toxicology, 2023, Volume: 39, Issue:6 Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Proliferation; Extracellular Vesicles; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel	2023
Parkin enhances sensitivity of paclitaxel to NPC by arresting cell cycle. Pathology, research and practice, 2020, Volume: 216, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Cell Cycle Checkpoints; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; Ubiquitin-Protein Ligases	2020
Implication of hsa_circ_0028007 in reinforcing migration, invasion, and chemo-tolerance of nasopharyngeal carcinoma cells. Journal of clinical laboratory analysis, 2020, Volume: 34, Issue:9 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Drug Resistance, Neoplasm; Female; Humans; Male; MicroRNAs; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Nose; Paclitaxel	2020
Silencing long non-coding RNA H19 combined with paclitaxel inhibits nasopharyngeal carcinoma progression. International journal of pediatric otorhinolaryngology, 2020, Volume: 138 Topics: Animals; Cell Line, Tumor; Cell Proliferation; Disease Progression; Gene Silencing; Humans; Mice; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; RNA, Long Noncoding; Xenograft Model Antitumor Assays	2020
Neferine sensitized Taxol-resistant nasopharygeal carcinoma to Taxol by inhibiting EMT via downregulating miR-130b-5p. Biochemical and biophysical research communications, 2020, 10-22, Volume: 531, Issue:4 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzylisoquinolines; Cell Line, Tumor; Cell Movement; Down-Regulation; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Inbred BALB C; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; Xenograft Model Antitumor Assays	2020
Exosomes derived from Taxol-resistant nasopharyngeal carcinoma (NPC) cells transferred DDX53 to NPC cells and promoted cancer resistance to Taxol. European review for medical and pharmacological sciences, 2021, Volume: 25, Issue:1 Topics: Aniline Compounds; Antineoplastic Agents, Phytogenic; Benzylidene Compounds; DEAD-box RNA Helicases; Drug Resistance, Neoplasm; Exosomes; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; Tumor Cells, Cultured	2021
Acylglycerol kinase promotes paclitaxel resistance in nasopharyngeal carcinoma cells by regulating FOXM1 via the JAK2/STAT3 pathway. Cytokine, 2021, Volume: 148 Topics: Animals; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Forkhead Box Protein M1; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 2; Male; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Neoplasms; Paclitaxel; Phosphotransferases (Alcohol Group Acceptor); STAT3 Transcription Factor; Up-Regulation	2021
Proteasome inhibitors decrease paclitaxel‑induced cell death in nasopharyngeal carcinoma with the accumulation of CDK1/cyclin B1. International journal of molecular medicine, 2021, Volume: 48, Issue:4 Topics: Antineoplastic Agents; Apoptosis; CDC2 Protein Kinase; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Cyclin B1; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; Proteasome Inhibitors; Signal Transduction	2021
LncRNA CCAT1 modulates the sensitivity of paclitaxel in nasopharynx cancers cells via miR-181a/CPEB2 axis. Cell cycle (Georgetown, Tex.), 2017, Apr-18, Volume: 16, Issue:8 Topics: Base Sequence; Carcinoma; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Male; MicroRNAs; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; RNA-Binding Proteins; RNA, Long Noncoding; Signal Transduction; Up-Regulation	2017
Targeted regulationof STAT3 by miR-29a in mediating Taxol resistance of nasopharyngeal carcinoma cell line CNE-1. Cancer biomarkers : section A of Disease markers, 2018, Volume: 22, Issue:4 Topics: Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; STAT3 Transcription Factor	2018
The efficacy of induction chemotherapy in the treatment of stage II nasopharyngeal carcinoma in intensity modulated radiotherapy era. Oral oncology, 2018, Volume: 85 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Hematologic Neoplasms; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Progression-Free Survival; Proportional Hazards Models; Radiotherapy, Intensity-Modulated; Retrospective Studies; Treatment Outcome	2018
The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest. Clinical epigenetics, 2018, 02-27, Volume: 10, Issue:1 Topics: Adaptor Proteins, Signal Transducing; beta Catenin; Carcinoma; Carrier Proteins; cdc25 Phosphatases; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; CpG Islands; DNA Methylation; Down-Regulation; Fluorouracil; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Nasopharyngeal Neoplasms; Neoplasm Proteins; Paclitaxel; Promoter Regions, Genetic; Signal Transduction	2018
Tumor Volume Reduction After Gemcitabine Plus Cisplatin Induction Chemotherapy in Locally Advanced Nasopharyngeal Cancer: Comparison with Paclitaxel and Cisplatin Regimens. Medical science monitor : international medical journal of experimental and clinical research, 2018, Nov-08, Volume: 24 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; China; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Paclitaxel; Retrospective Studies; Survival Analysis; Tumor Burden	2018
miR-29c regulates resistance to paclitaxel in nasopharyngeal cancer by targeting ITGB1. Experimental cell research, 2019, 05-01, Volume: 378, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Integrin beta1; MicroRNAs; Nasopharyngeal Neoplasms; Paclitaxel	2019
The MRVI1-AS1/ATF3 signaling loop sensitizes nasopharyngeal cancer cells to paclitaxel by regulating the Hippo-TAZ pathway. Oncogene, 2019, Volume: 38, Issue:32 Topics: A549 Cells; Activating Transcription Factor 3; Acyltransferases; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; HEK293 Cells; Hippo Signaling Pathway; Humans; MCF-7 Cells; Membrane Proteins; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; Phosphoproteins; Protein Serine-Threonine Kinases; RNA, Antisense; Signal Transduction; Transcription Factors	2019
Management of nasopharyngeal adenoid cystic carcinoma. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2013, Volume: 71, Issue:4 Topics: Adult; Analysis of Variance; Antineoplastic Agents; Carcinoma, Adenoid Cystic; Combined Modality Therapy; Cranial Nerve Neoplasms; Disease-Free Survival; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Paclitaxel; Palliative Care; Retrospective Studies; Treatment Outcome	2013
Concurrent chemoradiotherapy with nedaplatin plus paclitaxel or fluorouracil for locoregionally advanced nasopharyngeal carcinoma: Survival and toxicity. Head & neck, 2014, Volume: 36, Issue:10 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Disease Progression; Female; Fluorouracil; Humans; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Neoplasms; Organoplatinum Compounds; Paclitaxel; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated	2014
Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models. Cancer letters, 2014, Feb-01, Volume: 343, Issue:1 Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Cycle; Cell Line, Tumor; Cell Survival; Cisplatin; Enzyme Activation; Female; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Inhibitory Concentration 50; MAP Kinase Signaling System; Mice; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Paclitaxel; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Quinolines; TOR Serine-Threonine Kinases	2014
Prognostic value of tumor volume for patients with nasopharyngeal carcinoma treated with concurrent chemotherapy and intensity-modulated radiotherapy. Journal of cancer research and clinical oncology, 2014, Volume: 140, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Paclitaxel; Prognosis; Radiotherapy, Intensity-Modulated; Retrospective Studies; Young Adult	2014
Locoregional radiotherapy in patients with distant metastases of nasopharyngeal carcinoma at diagnosis. Chinese journal of cancer, 2013, Volume: 32, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Paclitaxel; Palliative Care; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Young Adult	2013
A combination of paclitaxel and siRNA-mediated silencing of Stathmin inhibits growth and promotes apoptosis of nasopharyngeal carcinoma cells. Cellular oncology (Dordrecht), 2014, Volume: 37, Issue:1 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Caspases; Cell Line, Tumor; Cell Movement; Cell Proliferation; Combined Modality Therapy; Female; G2 Phase Cell Cycle Checkpoints; HeLa Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Fluorescence; Nasopharyngeal Neoplasms; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering; Stathmin; Tumor Burden; Xenograft Model Antitumor Assays	2014
[Preliminary mechanism of paclitaxel enhanced radiation sensitivity for nasopharyngeal carcinoma cells]. Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery, 2014, Volume: 28, Issue:15 Topics: Apoptosis; Carcinoma; Cell Cycle; Cell Line, Tumor; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Radiation Tolerance	2014
Ephrin type‑A receptor 2 regulates sensitivity to paclitaxel in nasopharyngeal carcinoma via the phosphoinositide 3‑kinase/Akt signalling pathway. Molecular medicine reports, 2015, Volume: 11, Issue:2 Topics: Animals; Apoptosis; Carcinoma; Cell Line, Tumor; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rabbits; Receptor, EphA2; Signal Transduction	2015
MiR-634 sensitizes nasopharyngeal carcinoma cells to paclitaxel and inhibits cell growth both in vitro and in vivo. International journal of clinical and experimental pathology, 2014, Volume: 7, Issue:10 Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Humans; Mice, Nude; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Oligonucleotide Array Sequence Analysis; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Transfection; Tumor Burden; Xenograft Model Antitumor Assays	2014
Evaluation of a dansyl-based amino acid DNSBA as an imaging probe for apoptosis detection. Apoptosis : an international journal on programmed cell death, 2015, Volume: 20, Issue:3 Topics: Animals; Annexin A5; Apoptosis; Biological Transport; Carcinoma; Caspases; Cell Line, Tumor; Cell Membrane Permeability; Dansyl Compounds; Gene Expression; Humans; In Situ Nick-End Labeling; Injections, Subcutaneous; Kinetics; Mice; Mice, Inbred BALB C; Molecular Probes; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Optical Imaging; Paclitaxel; Phenylpropionates; Tumor Necrosis Factor-alpha	2015
MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel both in vitro and in vivo. Cancer biology & therapy, 2015, Volume: 16, Issue:2 Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Mice; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; Xenograft Model Antitumor Assays	2015
FOXC2 promotes chemoresistance in nasopharyngeal carcinomas via induction of epithelial mesenchymal transition. Cancer letters, 2015, Jul-28, Volume: 363, Issue:2 Topics: Animals; Anoikis; Carcinoma; Cell Proliferation; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Humans; Mice; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel	2015
[Study of the relationship among expression of Survivin and MRP and the drug resistance in human nasopharyngeal carcinoma]. Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery, 2015, Volume: 29, Issue:3 Topics: Antineoplastic Agents; Carcinoma; Cisplatin; Drug Resistance, Neoplasm; Fluorouracil; Humans; Immunohistochemistry; Inhibitor of Apoptosis Proteins; Lymphatic Metastasis; Multidrug Resistance-Associated Proteins; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nasopharynx; Paclitaxel; Survivin; Vincristine	2015
Nasopharyngeal carcinoma with bone marrow metastasis: positive response to weekly paclitaxel chemotherapy. Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:11 Topics: Bone Marrow Neoplasms; Carcinoma; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Paclitaxel	2015
Analysis on clinical characteristics and influencing factors of patients with locoregionally advanced nasopharyngeal carcinoma. Asian Pacific journal of cancer prevention : APJCP, 2015, Volume: 16, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorouracil; Follow-Up Studies; Gemcitabine; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Proportional Hazards Models; Radiotherapy, Intensity-Modulated; Risk Factors	2015
Long-term outcomes of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma treated with IMRT: a retrospective study. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Paclitaxel; Prognosis; Proportional Hazards Models; Radiotherapy, Intensity-Modulated; Retrospective Studies; Treatment Outcome	2016
Gene expression profiling of taxol-resistant nasopharyngeal carcinoma cells with siRNA-mediated FOLR1 downregulation. International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:9 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Transformation, Viral; Cluster Analysis; Down-Regulation; Drug Resistance, Neoplasm; Folate Receptor 1; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Nasopharyngeal Neoplasms; Oligonucleotide Array Sequence Analysis; Paclitaxel; RNA Interference; RNA, Small Interfering; Transfection	2015
Amplification of chromosome 8q21-qter associated with the acquired paclitaxel resistance of nasopharyngeal carcinoma cells. International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:10 Topics: Angiopoietin-1; Antineoplastic Agents, Phytogenic; Blotting, Western; Carcinoma; Cell Line, Tumor; Chromosomes, Human, Pair 8; Comparative Genomic Hybridization; Drug Resistance, Neoplasm; Gene Amplification; Gene Expression Profiling; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Oligonucleotide Array Sequence Analysis; Paclitaxel; Real-Time Polymerase Chain Reaction; Transcriptome	2015
[Pacilitaxel induces human nasopharyngeal carcinoma cell line CNE2 apoptosis and growth inhibition by suppressing PI3K/AKT/p53 signaling pathway]. Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery, 2015, Volume: 29, Issue:24 Topics: Apoptosis; Apoptosis Regulatory Proteins; Carcinoma; Cell Line, Tumor; Flow Cytometry; Humans; Membrane Potentials; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Tumor Suppressor Protein p53	2015
Ionizing radiation promotes advanced malignant traits in nasopharyngeal carcinoma via activation of epithelial-mesenchymal transition and the cancer stem cell phenotype. Oncology reports, 2016, Volume: 36, Issue:1 Topics: Antineoplastic Agents; Cadherins; Carcinoma; Cell Line, Tumor; Cell Movement; Cisplatin; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplastic Stem Cells; Paclitaxel; Proto-Oncogene Proteins c-myc; Radiation, Ionizing; Receptors, G-Protein-Coupled; Vimentin	2016
Silencing Op18/stathmin by RNA Interference Promotes the Sensitivity of Nasopharyngeal Carcinoma Cells to Taxol and High-Grade Differentiation of Xenografted Tumours in Nude Mice. Basic & clinical pharmacology & toxicology, 2016, Volume: 119, Issue:6 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; Combined Modality Therapy; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Grading; Paclitaxel; Random Allocation; RNA Interference; RNAi Therapeutics; Stathmin; Xenograft Model Antitumor Assays	2016
A triplet chemotherapy regimen of cisplatin, fluorouracil and paclitaxel for locoregionally recurrent nasopharyngeal carcinoma cases contraindicated for re-irradiation/surgery. Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:12 Topics: Adult; Aged; Antineoplastic Agents; Carcinoma; Cisplatin; Disease-Free Survival; Drug Therapy, Combination; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Leukopenia; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Prognosis; Re-Irradiation; Treatment Outcome	2016
Next generation deep sequencing identified a novel lncRNA n375709 associated with paclitaxel resistance in nasopharyngeal carcinoma. Oncology reports, 2016, Volume: 36, Issue:4 Topics: Antineoplastic Agents, Phytogenic; Carcinoma; Cell Line, Tumor; Drug Resistance, Neoplasm; High-Throughput Nucleotide Sequencing; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; Polymerase Chain Reaction; RNA, Long Noncoding; Transfection	2016
Value of intravoxel incoherent motion and dynamic contrast-enhanced MRI for predicting the early and short-term responses to chemoradiotherapy in nasopharyngeal carcinoma. Medicine, 2016, Volume: 95, Issue:35 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma; Chemoradiotherapy; Contrast Media; Diffusion Magnetic Resonance Imaging; Dose Fractionation, Radiation; Female; Gadolinium DTPA; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm, Residual; Organoplatinum Compounds; Paclitaxel; Perfusion; Predictive Value of Tests; ROC Curve; Time Factors; Treatment Outcome	2016
The FOXM1-ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells. Cell death & disease, 2017, 03-09, Volume: 8, Issue:3 Topics: Carcinoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Forkhead Box Protein M1; Gene Expression Regulation, Neoplastic; Humans; Multidrug Resistance-Associated Proteins; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Paclitaxel; Signal Transduction	2017
Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma. Cancer, 2008, Sep-15, Volume: 113, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Deoxycytidine; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Gemcitabine; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Nasopharyngeal Neoplasms; Paclitaxel; Prognosis; Quality of Life; Survival Rate	2008
Folate-mediated targeting of albumin conjugates of paclitaxel obtained through a heterogeneous phase system. International journal of pharmaceutics, 2009, Dec-01, Volume: 382, Issue:1-2 Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Carrier Proteins; Cell Proliferation; Cell Survival; Chemistry, Pharmaceutical; Chromatography, Gel; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Stability; Folate Receptors, GPI-Anchored; Folic Acid; HT29 Cells; Humans; Inhibitory Concentration 50; KB Cells; Nasopharyngeal Neoplasms; Paclitaxel; Polyethylene Glycols; Receptors, Cell Surface; Serum Albumin; Solubility; Technology, Pharmaceutical; Triazines	2009
Paclitaxel with cisplatin in concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2010, Volume: 267, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cisplatin; Drug Therapy, Combination; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Paclitaxel; Radiotherapy Dosage; Young Adult	2010
[Resveratrol increases sensitivity of CNE2 cells to chemotherapeutic drugs under hypoxia]. Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine, 2009, Volume: 7, Issue:10 Topics: Antineoplastic Agents, Phytogenic; Carcinoma; Cell Hypoxia; Cell Line, Tumor; Down-Regulation; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Multidrug Resistance-Associated Proteins; Nasopharyngeal Neoplasms; Paclitaxel; Resveratrol; Stilbenes	2009
[Down-regulation of Twist1 increases the sensitivity of nasopharyngeal carcinoma cell lines HNE1 to taxol]. Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery, 2009, Volume: 44, Issue:6 Topics: Apoptosis; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Nasopharyngeal Neoplasms; Nuclear Proteins; Paclitaxel; RNA Interference; RNA, Small Interfering; Twist-Related Protein 1	2009
[Expression and significance of Survivin mRNA in xenotransplanted nasopharyngeal carcinoma treated by paclitaxel combined with radiotherapy]. Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery, 2009, Volume: 23, Issue:17 Topics: Animals; Brachytherapy; Cell Line, Tumor; Humans; Inhibitor of Apoptosis Proteins; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Paclitaxel; Repressor Proteins; RNA, Messenger; Survivin; Xenograft Model Antitumor Assays	2009
Reversal of taxol resistance by cisplatin in nasopharyngeal carcinoma by upregulating thromspondin-1 expression. Anti-cancer drugs, 2010, Volume: 21, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Humans; Nasopharyngeal Neoplasms; Paclitaxel; Repressor Proteins; Signal Transduction; Thrombospondin 1; Up-Regulation	2010
[Analysis of responses and prognostic factors in different chemotherapy regimens for metastatic nasopharyngeal carcinoma: a report of 171 cases]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2009, Volume: 31, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Paclitaxel; Proportional Hazards Models; Remission Induction; Retrospective Studies; Survival Rate; Taxoids; Young Adult	2009
Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: experience of 370 consecutive cases. BMC cancer, 2010, Feb-10, Volume: 10 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Radiotherapy; Survival Rate; Treatment Outcome	2010
Increase of the therapeutic effect by treating nasopharyngeal tumor with combination of HER-2 siRNA and paclitaxel. International journal of oncology, 2010, Volume: 36, Issue:4 Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chemotherapy, Adjuvant; Genetic Therapy; Humans; Mice; Nasopharyngeal Neoplasms; Paclitaxel; Receptor, ErbB-2; RNA Interference; RNA, Small Interfering; Time Factors; Transfection; Trastuzumab; Tumor Burden; Xenograft Model Antitumor Assays	2010
Induction chemotherapy with carboplatin and taxol followed by radiotherapy and concurrent weekly carboplatin + taxol in locally advanced nasopharyngeal carcinoma. Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Neoplasm Metastasis; Paclitaxel; Retrospective Studies; Survival Rate	2011
[Relationship between the insulin-like growth factor 1 receptor signaling pathway and the resistance of nasopharyngeal carcinoma to cetuximab]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2010, Volume: 32, Issue:8 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cetuximab; Cisplatin; Drug Resistance, Neoplasm; Fluorouracil; Humans; Nasopharyngeal Neoplasms; Paclitaxel; Phosphorylation; Receptor, IGF Type 1; Signal Transduction	2010
[Role of folate receptor 1 in paclitaxel-resistance of nasopharyngeal carcinoma cells]. Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery, 2010, Volume: 45, Issue:12 Topics: Cell Line, Tumor; Drug Resistance, Neoplasm; Folate Receptor 1; Humans; Nasopharyngeal Neoplasms; Paclitaxel	2010
Inhibition of α folate receptor resulting in a reversal of taxol resistance in nasopharyngeal carcinoma. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2012, Volume: 146, Issue:2 Topics: Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Carcinoma; Drug Resistance, Neoplasm; Folate Receptor 1; Folic Acid; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; Tumor Cells, Cultured	2012
Radiofrequency ablation combined with systemic chemotherapy in nasopharyngeal carcinoma liver metastases improves response to treatment and survival outcomes. Journal of surgical oncology, 2012, Sep-01, Volume: 106, Issue:3 Topics: Carcinoma; Catheter Ablation; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Retrospective Studies	2012
[Differential expression of taxol resistance and taxol resistance reversal related genes in nasopharyngeal carcinoma by cDNA microarray]. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2012, Volume: 37, Issue:1 Topics: Adaptor Proteins, Signal Transducing; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cell Line, Tumor; Cytochrome P-450 CYP1A1; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Nasopharyngeal Neoplasms; Oligonucleotide Array Sequence Analysis; Paclitaxel; Proteins; Receptors, Tumor Necrosis Factor; TWEAK Receptor	2012
Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma. Journal of cancer research and clinical oncology, 2012, Volume: 138, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; Retrospective Studies	2012
[Synergistic interactions of TRAIL and paclitaxel on the nasopharyngeal carcinoma cell lines in vitro]. Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery, 2012, Volume: 26, Issue:7 Topics: Apoptosis; Carcinoma; Cell Line, Tumor; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; Receptors, TNF-Related Apoptosis-Inducing Ligand	2012
[Study of sequence-dependent in vitro effects of zoledronic acid and paclitaxel upon human nasopharyngeal carcinoma cell line HNE1]. Zhonghua yi xue za zhi, 2012, Apr-24, Volume: 92, Issue:16 Topics: Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Humans; Imidazoles; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; Zoledronic Acid	2012
Genomic methylation profiling combined with gene expression microarray reveals the aberrant methylation mechanism involved in nasopharyngeal carcinoma taxol resistance. Anti-cancer drugs, 2012, Volume: 23, Issue:8 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Azacitidine; Carcinoma; Cell Line, Tumor; Decitabine; DNA Methylation; Drug Resistance, Neoplasm; Gene Expression Profiling; Genomics; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Oligonucleotide Array Sequence Analysis; Paclitaxel	2012
Metastatic human papillomavirus-positive nasopharyngeal carcinoma with an unusual pattern of aggressive hematogenous spread. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Nov-10, Volume: 30, Issue:32 Topics: Alphapapillomavirus; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biomarkers, Tumor; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Diagnosis, Differential; Drug Administration Schedule; Fatal Outcome; Fluorodeoxyglucose F18; Fluorouracil; Heart Failure; Humans; Hypertension, Pulmonary; Hypoxia; Immunohistochemistry; Laryngoscopy; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Papillomavirus Infections; Positron-Emission Tomography; Pulmonary Artery; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Randomized Controlled Trials as Topic; Thrombophilia; Tomography, X-Ray Computed; Vascular Neoplasms	2012
Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell lines. Investigational new drugs, 2013, Volume: 31, Issue:3 Topics: Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cisplatin; Heterocyclic Compounds, 3-Ring; Humans; Mitogen-Activated Protein Kinases; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases	2013
[Effect of low-molecular-weight heparin combined with paclitaxel on the invasiveness and migration of nasopharyngeal carcinoma cells in vitro]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2012, Volume: 32, Issue:11 Topics: Carcinoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; Glucuronidase; Heparin Lyase; Heparin, Low-Molecular-Weight; Humans; Matrix Metalloproteinase 9; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; Tissue Inhibitor of Metalloproteinase-1	2012
Serum lactic dehydrogenase strongly predicts survival in metastatic nasopharyngeal carcinoma treated with palliative chemotherapy. European journal of cancer (Oxford, England : 1990), 2013, Volume: 49, Issue:7 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma; Cisplatin; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; L-Lactate Dehydrogenase; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Outcome Assessment, Health Care; Paclitaxel; Palliative Care; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Retrospective Studies; Young Adult	2013
Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells. Oncogene, 2004, Jan-15, Volume: 23, Issue:2 Topics: Drug Resistance, Neoplasm; Female; Gene Amplification; Gene Expression Regulation, Neoplastic; Helix-Loop-Helix Motifs; Humans; Inhibitory Concentration 50; Male; Nasopharyngeal Neoplasms; Nuclear Proteins; Ovarian Neoplasms; Paclitaxel; Prostatic Neoplasms; Transcription Factors; Tumor Cells, Cultured; Twist-Related Protein 1; Urinary Bladder Neoplasms; Vincristine	2004
Id-1-induced Raf/MEK pathway activation is essential for its protective role against taxol-induced apoptosis in nasopharyngeal carcinoma cells. Carcinogenesis, 2004, Volume: 25, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Line, Tumor; Enzyme Activation; Humans; Inhibitor of Differentiation Protein 1; MAP Kinase Kinase Kinases; Nasopharyngeal Neoplasms; Paclitaxel; Phosphorylation; Proto-Oncogene Proteins c-raf; Repressor Proteins; Signal Transduction; Transcription Factors	2004
Inhibitors of epidermoid growth factor receptor suppress cell growth and enhance chemosensitivity of nasopharyngeal cancer cells in vitro. Oncology, 2005, Volume: 68, Issue:4-6 Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Drug Therapy, Combination; ErbB Receptors; Fluorouracil; Humans; In Vitro Techniques; Nasopharyngeal Neoplasms; Paclitaxel; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Tumor Cells, Cultured	2005
Evidence of a novel antiapoptotic factor: role of inhibitor of differentiation or DNA binding (Id-1) in anticancer drug-induced apoptosis. Cancer science, 2007, Volume: 98, Issue:3 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Catechin; Cell Line, Tumor; Cell Survival; Cisplatin; Down-Regulation; Doxorubicin; Etoposide; Female; HeLa Cells; Humans; Inhibitor of Differentiation Protein 1; Liver Neoplasms; Male; Mechlorethamine; Methotrexate; Mitomycin; Nasopharyngeal Neoplasms; Paclitaxel; Prostatic Neoplasms; Vincristine	2007
Anti-apoptotic role of TWIST and its association with Akt pathway in mediating taxol resistance in nasopharyngeal carcinoma cells. International journal of cancer, 2007, May-01, Volume: 120, Issue:9 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Nasopharyngeal Neoplasms; Nuclear Proteins; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Proto-Oncogene Proteins c-akt; Twist-Related Protein 1; Vincristine	2007
[Radiosensitization of paclitaxel combined with radiation on nasopharygneal carcinoma cells (CNE-I) in vitro]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2007, Volume: 29, Issue:9 Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Humans; Nasopharyngeal Neoplasms; Paclitaxel; Particle Accelerators; Radiation Tolerance; Radiation-Sensitizing Agents	2007
Paclitaxel-induced severe neuropathy in patients with previous radiotherapy to the head and neck region. Journal of the National Cancer Institute, 1996, Jul-17, Volume: 88, Issue:14 Topics: Adult; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Paclitaxel; Peripheral Nervous System Diseases; Radiotherapy Dosage	1996
Choroid metastasis of undifferentiated nasopharyngeal carcinoma. The Journal of laryngology and otology, 1998, Volume: 112, Issue:7 Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Choroid Neoplasms; Combined Modality Therapy; Fatal Outcome; Humans; Male; Nasopharyngeal Neoplasms; Paclitaxel; Radiotherapy, High-Energy	1998
Taxol reduces cytosolic E-cadherin and beta-catenin levels in nasopharyngeal carcinoma cell line TW-039: cross-talk between the microtubule- and actin-based cytoskeletons. Journal of cellular biochemistry, 2000, Sep-14, Volume: 79, Issue:4 Topics: Actins; Adenomatous Polyposis Coli Protein; Antineoplastic Agents, Phytogenic; beta Catenin; Cadherins; Calcium-Calmodulin-Dependent Protein Kinases; Cell Size; Cytoskeletal Proteins; Cytoskeleton; Cytosol; Glycogen Synthase Kinase 3; Humans; Microtubules; Nasopharyngeal Neoplasms; Neoplasm Proteins; Paclitaxel; Phosphorylation; Trans-Activators; Tumor Cells, Cultured; Tyrosine	2000
Activation of MAD 2 checkprotein and persistence of cyclin B1/CDC 2 activity associate with paclitaxel-induced apoptosis in human nasopharyngeal carcinoma cells. Apoptosis : an international journal on programmed cell death, 2000, Volume: 5, Issue:3 Topics: Antibodies; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Calcium-Binding Proteins; Carrier Proteins; CDC2 Protein Kinase; Cell Cycle; Cell Cycle Proteins; Cyclin B; Cyclin B1; DNA Fragmentation; Electroporation; Fungal Proteins; Humans; Models, Biological; Nasopharyngeal Neoplasms; Nuclear Proteins; Paclitaxel; Precipitin Tests; Tumor Cells, Cultured	2000
Evaluation of GL331 in combination with paclitaxel: GL331's interference with paclitaxel-induced cell cycle perturbation and apoptosis. Anti-cancer drugs, 2001, Volume: 12, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Calcium-Binding Proteins; Carrier Proteins; CDC2 Protein Kinase; Cell Cycle; Cell Cycle Proteins; Cell Nucleus; Cyclin B; Cyclin B1; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Antagonism; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Etoposide; Flow Cytometry; Fungal Proteins; Humans; Nasopharyngeal Neoplasms; Nuclear Proteins; Paclitaxel; Precipitin Tests; Protein Kinases; Tetrazolium Salts; Thiazoles; Toxicity Tests; Tumor Cells, Cultured	2001
Apoptosis induced by low-dose paclitaxel is associated with p53 upregulation in nasopharyngeal carcinoma cells. International journal of cancer, 2002, Jan-10, Volume: 97, Issue:2 Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-X Protein; Blotting, Western; Caspase 3; Caspase Inhibitors; Caspases; Cell Survival; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Genes, bcl-2; Humans; Nasopharyngeal Neoplasms; Paclitaxel; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Up-Regulation	2002